Design, synthesis and molecular docking of new pyrazole-thiazolidinones as potent anti-inflammatory and analgesic agents with TNF-α inhibitory activity.
Clicks: 689
ID: 265398
2021
Article Quality & Performance Metrics
Overall Quality
Improving Quality
83.3
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
81.5
/100
688 views
553 readers
Trending
AI Quality Assessment
🥈
High Quality
84.0
/100
Academic Rigor
88.0%
Novelty
78.0%
Clarity
85.0%
Key Strengths
- Well-defined research question
- Strong synthesis and characterization of new compounds
- In-vivo anti-inflammatory and analgesic evaluation
Areas for Improvement
- The abstract does not mention the specific animal model used.
- The abstract does not mention the number of animals used in each group.
- The abstract does not mention the statistical methods used to analyze the data.
AI Recommendations
Consider providing more details about the statistical analysis performed and the specific animal model used in the in-vivo studies. Expanding on the limitations of the study would also be beneficial.
Enhanced v2.0 Analysis NISO/DORA Compliant
NISO/DORA Compliant
High Impact
📊 Established
Topic Trend
2025 Relevance
Relevance
0%
Importance
0%
Authorship
Unknown
Authors
0
Diversity
0%
Research Integrity
COPE Standards
Integrity
0%
Innovation
0%
Interdisciplinary Value
🔀 Cross-disciplinary
68%
Practical Impact Potential
Real-world Applications
75%
Enhanced Evaluation v2.0: Following NISO RP-25-2016, DORA 2025, and COPE assessment standards with 13 quality dimensions.
Abstract
A new set of derivatives bearing pyrazole-methylenehydrazono-thiazolidinone scaffold 4-23 was designed, synthesized and confirmed by different spectroscopic means and elemental analyses. In-vivo anti-inflammatory and ulcerogenic evaluation was performed for all the newly synthesized derivatives using indomethacin, celecoxib and diclofenac as standard drugs. The compounds 5, 10, 15, 17, 21, 22 appeared to be the most promising candidates producing rapid onset and long duration of anti-inflammatory activity as well as promising GIT safety profile. Furthermore, analgesic evaluation revealed that the compounds 5, 10, 15 and 22 produced potent and long acting analgesia accompanied with significant inhibition of the inflammatory cytokine TNF-α level in comparison with the standard drugs. Molecular docking study of the latter derivatives was also carried out to rationalize their binding affinities and their modes of interactions with the active site of TNF-α.
| Reference Key |
abd-elkarim2021designbioorganic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Abd El-Karim, Somaia S;Mohamed, Hanaa S;Abdelhameed, Mohamed F;El-Galil E Amr, Abd;Almehizia, Abdulrahman A;Nossier, Eman S; |
| Journal | Bioorganic chemistry |
| Year | 2021 |
| DOI |
S0045-2068(21)00204-2
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.